2015

“EVENTS” 3D text surrounded by calendar dates. Part of a series.

  • Milagen is pleased to receive from the Mexico Regulatory Agency COFEPRIS the approval for the commercialization in Mexico to the public and private diagnostic sector, through its partnership with Grupo Columbia and Servacare, of Class II IVD product Pap PLUS Kit as a Kit for the collection of cervical samples for the detection of cervical cancer and for the detection of HPV, under registration number 2541R2014SSA with validity until 2019.
  • Milagen is pleased to receive from the Mexico Regulatory Agency COFEPRIS the approval for the commercialization in Mexico to the public and private diagnostic sector, of the following Milagen IVD products of Class I, with validity until 2019:
  • Liquid preservative solution Registration #1998R2014SSA
  • p16 Registration # 2364R2014SSA
  • Ki67┬áRegistration # 2359R2014SSA
  • Anti-HPV┬áRegistration # 2369R2014SSA
  • Milagen is pleased to enter in a strategic collaboration with the prestigious Institute of Health (INCAN, INCMNSZ) in Mexico to conduct a major clinical study with the aim of finding superior biomarkers for relapse and surveillance of patients with cancer